We continue to monitor COVID-19, flu and other respiratory viruses in our communities. Read the most current information about prevention, testing and where to go if you're sick.

COVID-19 Information

Preparing for Baby Classes and Support Groups

At MoBap, we believe that supporting healthy and happy babies begins with supporting their parents. That’s why we offer classes and support groups to guide new parents each step along the exciting path of parenthood.

Read more

MoBap Mom and AFE Survivor Shares Story and Gives Back

First-time mothers are often nervous before their babies are born. Experienced mothers are a little more comfortable because they know what to expect. For Courtney Johnson, a 35-year-old from Chesterfield, she was an experienced mother but was nervous because she knew something wasn't right. 

Read more
Terrell and his team of caregivers prepare to go outside.

COVID-19 Patient Makes Recovery After 49 Days on ECMO

The ICU team at Missouri Baptist Medical Center had seen more than their share of the critically ill from COVID-19 for nearly eighteen months. On April 26, 2021, they met Terrell Brown.

Read more

Getting Back into the Swing After Breast Cancer

As a former marketing executive at Anheuser-Busch and a sales and operations vice president with Staples, Geri saw her diagnosis as just another challenge that needed an execution strategy.

Read more

Did You Know?

As the COVID-19 vaccine becomes more widely available, many people wonder whether it's right for them. BJC HealthCare wants you to have the information you need to make the right decision for yourself and your loved ones.

Read more
First2345791011Last

Related Content

MoBap Offers a New FDA-Approved Treatment for People With Advanced Prostate Cancer
Elizabeth
/ Categories: Cancer, Innovations in Care

MoBap Offers a New FDA-Approved Treatment for People With Advanced Prostate Cancer

Prostate cancer is the second leading cause of cancer death in American men, with one in eight males diagnosed in their lifetime.

On March 23, 2022, prostate cancer treatment for those with advanced disease took a step forward with the FDA approving the first targeted therapy for the treatment of progressive, PSMA-positive prostate cancer that has spread or metastasized to other parts of the body.

Vincent Joe, MD, a radiation oncologist on staff at Missouri Baptist Medical Center, explained that the new medication is a type of precision radiotherapy that targets a specific protein on the prostate cancer cells called prostate-specific membrane antigen, or PSMA. When it attaches, the medicine delivers a concentrated form of radiotherapy directly to the cancer cells no matter where they are in the body.

"This therapy is designed for those whose cancer isn't responding to standard treatment options like chemotherapy or anti-testosterone hormone treatment. This new therapy has been shown to extend the life of people with terminal prostate cancer and slow down cancer's spread," Dr. Joe said.

For patients, the first step is to have a PSMA positron emission tomography (PET) scan. This test can tell doctors if the prostate cancer has spread to other parts of the body, as well as help to determine their
eligibility for the new drug.

Dr. Joe added that if a patient qualifies for the new therapy, it's given through an IV infusion. "Patients receive an infusion every six weeks for a total of six infusions over 30 weeks. In between treatments, we check blood work to make sure they are tolerating the medication and can modify the dosage if necessary."

Missouri Baptist Medical Center is one of three sites in Missouri that is currently offering this treatment.

"While this treatment is not a cure, it is a very promising therapy for patients who have exhausted other options," Dr. Joe said.

For more information about this treatment, call: 314-996-5199.

 

Print
13081 Rate this article:
No rating

Find a Doctor or Make an Appointment

Our new search tool will help you choose a doctor or health care provider that is best for you or your family.

Search Now